The ZIKAVAX project brings together a small but multidisciplinary consortium whose partners from public and private sectors have complementary expertise in vaccine Research and Development (R&D) - from antigen discovery, over preclinical R&D and down to the early and mid-stage clinical testing of vaccine candidates in clinical trials - management, communication and innovation. 

The coordination of the ZIKAVAX project is assured by the Coordinator (Dr Odile Leroy, European Vaccine Initiative (EVI)) assisted by the Management Team (EVI) and the Project Steering Committee (PSC).  To increase the chance of success towards the set objectives, i.e. the development of a safe and effective Zika vaccine, the consortium will be supported by a Scientific and Ethics Advisory Committee (SEAC) that will provide strategic inputs into scientific-technical, public health and ethical issues.